Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From bench to bedside: the history and progress of CAR T cell therapy
Aroshi Mitra, Amrita Barua, Luping Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 191

Showing 26-50 of 191 citing articles:

Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review
Tony Joseph, Jimmy Sánchez, Ahmed Nadeem Abbası, et al.
Current Oncology Reports (2025)
Open Access | Times Cited: 1
Protein Recognition Methods for Diagnostics and Therapy
Ryne Montoya, Peter Deckerman, Mustafa O Guler
BBA Advances (2025) Vol. 7, pp. 100149-100149
Open Access | Times Cited: 1
Clinical Proof-of-Concept of a Non-Gene Editing Technology Using miRNA-Based shRNA to Engineer Allogeneic CAR T-Cells
Caroline Lonez, Jennifer Bolsée, Fanny Huberty, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1658-1658
Open Access | Times Cited: 1
Basic Concepts and Indications of CAR T Cells
J. Berg, Heinz Laübli, Nina Khanna, et al.
Hämostaseologie (2025) Vol. 45, Iss. 01, pp. 014-023
Closed Access | Times Cited: 1
Exosomes in review: A new frontier in CAR-T cell therapies
Jiguang Wang, Samuel J Schellenberg, Athena Demeros, et al.
Neoplasia (2025) Vol. 62, pp. 101147-101147
Closed Access | Times Cited: 1
CAR T Cells in Lung Cancer: Targeting Tumor-Associated Antigens to Revolutionize Immunotherapy
Sattam Khulaif Alenezi
Pathology - Research and Practice (2025), pp. 155947-155947
Closed Access | Times Cited: 1
Rationally designed approaches to augment CAR-T therapy for solid tumor treatment
Chaojie Zhu, Qing Wu, Tao Sheng, et al.
Bioactive Materials (2023) Vol. 33, pp. 377-395
Open Access | Times Cited: 22
Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system
Kenny Misael Calvillo‐Rodríguez, Helen Yarimet Lorenzo-Anota, Cristina Rodríguez‐Padilla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
Maria Florencia Giraudo, Zachary Jackson, Indrani Das, et al.
Pathogens and Immunity (2024) Vol. 9, Iss. 1, pp. 1-17
Open Access | Times Cited: 8
Immunotherapy in mastitis: state of knowledge, research gaps and way forward
Afnan Saleem, Sahar Saleem, Faith Omonijo, et al.
Veterinary Quarterly (2024) Vol. 44, Iss. 1, pp. 1-23
Open Access | Times Cited: 8
Advances in targeting tumor microenvironment for immunotherapy
Lugang Wang, Liubo Zhang, Zhen Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy
Salima Shebbo, Najat Binothman, Manar Darwaish, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Identification and characterisation of novel CAR‐T cells to target IL13Rα2 positive human glioma in vitro and in vivo
Pamela Leland, Heba Degheidy, Ashley Lea, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 7
Dissolving microneedles for transdermal drug delivery in cancer immunotherapy
Maya Xiang, Chunli Yang, Li Zhang, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 24, pp. 5812-5822
Closed Access | Times Cited: 7
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
Yun Chang, Ming‐Yang Chang, Xiaoping Bao, et al.
Bioactive Materials (2024) Vol. 42, pp. 379-403
Open Access | Times Cited: 7
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
Anneliene Hechtelt Jonker, Elena-Alexandra Tãtaru, Holm Graeßner, et al.
Nature Reviews Drug Discovery (2024) Vol. 24, Iss. 1, pp. 40-56
Closed Access | Times Cited: 7
Synthetic GPCRs for programmable sensing and control of cell behaviour
Nicholas A. Kalogriopoulos, Reika Tei, Yuqi Yan, et al.
Nature (2024)
Open Access | Times Cited: 7
Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer
Hong Ma, Jeeban P. Das, Conor Prendergast, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9019-9038
Open Access | Times Cited: 16
Torque Teno Virus DNA Load in Blood as an Immune Status Biomarker in Adult Hematological Patients: The State of the Art and Future Prospects
Eliseo Albert, Estela Giménez, Rafael Hernani, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 459-459
Open Access | Times Cited: 6
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy
Alexandra Dreyzin, Alexander W. Rankin, Katia Luciani, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 7, pp. 745-763
Closed Access | Times Cited: 6
Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations
Beatriz Guijarro-Albaladejo, Cristina Marrero-Cepeda, Eduardo Rodríguez‐Arbolí, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review
Bibhu Prasad Satapathy, Pooja Sheoran, Rohit Yadav, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
The Current Landscape of Secondary Malignancies after CAR T-Cell Therapies: How Could Malignancies Be Prevented?
Stella Bouziana, Dimitrios Bouzianas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9518-9518
Open Access | Times Cited: 5
Gastric Cancer Signaling Pathways and Therapeutic Applications
Mingfang Wu, Shiman Yuan, Kai Liu, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 5
Drug-induced interstitial lung disease: a narrative review of a clinical conundrum
Megan Harrison, Grace Kavanagh, Tamera J. Corte, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 1-2, pp. 23-39
Closed Access | Times Cited: 4

Scroll to top